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Purpose: Clinical differentiation of choroidal pigmented lesions is sometimes difficult. 
  Choroidal melanoma is the most prevalent primary neoplasia among malignant ocular tumors, 
and metastasis often occurs before the primary tumor is diagnosed. Therefore, early detection is 
essential. We investigated the imaging properties of clinically diagnosed melanocytic choroidal 
tumors using a nonmydriatic ultra-wide-field scanning laser ophthalmoscope (SLO) with two 
laser wavelengths to distinguish benign from malignant lesions. Repeated standardized ultrasound 
(US) evaluation provided reference standard.
Methods: In a consecutive series of 49 patients with clinically diagnosed melanocytic   choroidal 
tumors in one eye, 29 had established melanoma (defined by proven growth on repeated US 
follow-up) and 20 had nevi (defined by no malignancy according to clinical, US, and growth 
  characteristics for at least 2 years). All patients underwent clinical examination, undilated 
Optomap (Optos PLC, Dunfermline, Fife, Scotland, UK) imaging, standardized US   examination, 
and standard retinal photography. Measurements of the tumor base using the Optomap software 
were compared with US B-scan measurements. Imaging characteristics from the SLO images 
were correlated with the structural findings in the two patient groups.
Results: Measurements of tumor base correlated well between SLO and US with r = 0.61 
(T-direction) and r = 0.51 (L-direction). On SLO imaging, typical malignant lesions appeared 
dark on the red laser channel and bright on the green laser channel. Based on those simple 
binary characteristics, a sensitivity of 76% at a specificity of 70% was obtained for a correct 
classification of lesions. When analogous to clinical examination lesion size, margin touching 
the optic disc, and existence of subretinal fluid were additionally considered, 90% sensitivity 
at 82% specificity was obtained.
Conclusions: In this first, limited series, nonmydriatic SLO imaging with two laser wave-
lengths permitted to differentiate malignant ocular tumors from nonmalignant lesions with high 
  diagnostic accuracy. Additional parameters may further enhance diagnostic properties, but larger 
patient series are required to validate our findings and prove the diagnostic properties.
Keywords: choroidal melanoma, nevus, imaging, ultra-wide-field scanning laser ophthal-
moscopy
Introduction
Pigmented choroidal lesions are a common finding on the ocular fundus. Most of 
these lesions can be differentiated by their clinical appearance together with their 
  angiographic and ultrasonographic (US) characteristics. However, distinguishing 
between benign and malignant lesions is sometimes difficult. Most choroidal lesions are 
benign, and the   overall incidence of malignancies in the form of choroidal   melanoma 
is low (  approximately six new cases per million per year in the United States). Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
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  Nonetheless, choroidal melanoma is the most frequent 
primary malignant intraocular tumor and the second most 
frequent malignant melanoma in the body.1 Benign choroidal 
nevi are common and can be found in approximately 6% of 
the US population.2–5 Choroidal melanoma can arise de novo 
as well as from pre-existing choroidal nevi.6–8 Therefore, 
  choroidal nevi should be monitored regularly. In addition, 
early detection of malignant lesions is extremely important 
because progressive tumors have a very poor prognosis.9–12
On the other hand, especially in smaller lesions, dif-
ferentiating choroidal nevi from small choroidal melanoma 
is difficult and concern about malignant transformation 
is always present.12–14 Consequently, several studies have 
attempted to distinguish small choroidal melanomas from 
choroidal nevi and to identify risk factors for growth of small 
choroidal tumors.1,12,15,16
Biomicroscopy of the fundus and photographic color 
fundus imaging are the most commonly used techniques for 
diagnosing and documenting choroidal lesions.   However, both 
techniques are sometimes insufficient to   differentiate lesions 
accurately. Even with combined clinical,   angiographic, and US 
findings, diagnosis sometimes remains uncertain.1,11,12,14–16
Recently, a novel ultra-wide-field scanning laser 
  ophthalmoscope (SLO) with two laser wavelengths, the 
Optomap Panoramic 200MA (Optos PLC, Dunfermline, 
Fife,   Scotland, UK), was developed. The system allows 
  nonmydriatic imaging and by differentiating the two laser 
scans, provides additional image information. Optomap 
Panoramic 200MA images encompass not only the posterior 
pole but also extend over the equator.17
This study evaluates measurements of the tumor base 
using the Optomap Vantage V2 software vs the reference 
standard, standardized US evaluation, which is a well estab-
lished, highly sensitive, and specific method to measure and 
differentiate intraocular tumors.18,19 In addition, the diagnostic 
properties of Panoramic 200MA images to separate benign 
from malignant lesions of the ocular fundus were investi-
gated. For this, a number of imaging characteristics from the 
two-wavelength SLO images were investigated for their abil-
ity to differentiate a nevus and melanoma patient group.
Methods
Patients
In a consecutive series of 49 patients (20 men and 29 women) 
comprising 49 eyes (26 OD and 23 OS) with clinically 
diagnosed melanocytic choroidal tumors, 29 had   established 
melanoma (defined by proven growth on repeated US 
  follow-up). Of these patients, 20 had received radiation 
  therapy (9 in total showed radiation signs   funduscopically) 
and 9 were untreated at the time of examination. The 
  remaining 20 patients had nevi as defined by no malignancy 
based on clinical and US examinations and no growth for at 
least 2 years. The median age of patient was 64 years (range, 
39–85 years). After informed consent was obtained, all 
patients underwent clinical examination, undilated Optomap 
imaging, standardized US examination, and standard retinal 
photography. The study fully conformed to the principles 
expressed in the Declaration of Helsinki, and Institutional 
Review Board approval was obtained.
standardized Us examination
The same equipment was used for all patients for A-scan and 
B-scan examination (Ultrasound Cinescan-S, Memory Card 
Version S 2.07; QuantelMedical,   Clermont-Ferrand, France). 
We followed the specific criteria described by Ossoinig 
et al20 to evaluate an intraocular tumor with   standardized 
US. In brief, the eye was open during examination and each 
examination consisted of a preliminary topographic B-scan 
evaluation. B-scan was also used to evaluate the shape of 
the lesion and to measure both the maximum transverse, 
circumferential basal tumor diameter (T-direction) and 
longitudinal, radial basal tumor diameter (L-direction) of 
the tumor base with calipers.20 A relatively low gain setting 
was used to obtain the best measurement, and we identified 
the inner sclera as the first distinct line of the tumor base 
that was continuous with the surrounding   fundus. Gain 
  settings for B-scan evaluation were not specified. Tumor 
height measurements were then obtained only with the 
  standardized A-scan, not the B-scan.20 The standardized 
A-scan instrument was first set at tissue sensitivity, accord-
ing to the principles described by Ossoinig et al20 with the 
probe placed at the opposite side of the tumor. Careful atten-
tion was paid to the perpendicular orientation of the sound 
beam with respect to the point of maximal tumor elevation 
and the inner sclera. Once the tumor surface spike and the 
scleral spike were displayed with their maximum height, 
we lowered the gain while continuously monitoring the 
screen until the peaks were distinct and clear. We obtained 
measurements by placing calipers on the peak of the tumor 
surface spike and the inner scleral spike and then took at 
least three high-quality images. The examiner selected the 
photograph representing the most accurate measurement and 
recorded the tumor height. Other documented parameters 
were shape, internal reflectivity (low, medium, and high), 
internal structure (homogeneous-regular, heterogeneous-
regular, and irregular), vascularity (positive and negative), 
retinal detachment (positive and negative), and location 
(posterior, equator, and anterior).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Optomap imaging
Optomap imaging was performed without pupil dilation, 
prior to and independent of clinical and US examinations. 
Optomap imaging consisted of taking several images and 
saving the best image per eye for grading. The instrument 
takes one image in approximately 0.25 seconds thus avoiding 
motion artifacts. Total scanning time was about 3–5 minutes, 
which included patient positioning, and was performed by an 
experienced technician or one of the authors. Basic opera-
tion of the Optomap Panoramic 200MA is an SLO with two 
scanning laser wavelengths: one green (532 nm) and one red 
(633 nm). The two images can be viewed separately or super-
imposed to yield semirealistic color imaging. The instrument 
requires a small optical path of only 2 mm and its mirror 
design allows obtaining wide-field images of approximately 
180–200° without pupil dilatation. The optical resolution with 
the specific instrument used in our study was 3,900–3,072 
pixels, resulting in approximately 17–20 pixels per degree. 
Due to the SLO, principal images of high contrast and sharp-
ness were obtained, which showed less susceptibility to media 
opacities than conventional photography.21
image analysis and statistics
The retinal images were loaded from the server to a viewing 
station (equipped with a conventional 17-inch noncalibrated 
cathode ray color monitor) via network and assessed with the 
Optomap Vantage V2 software. This software allows basic 
image manipulations such as changing contrast and bright-
ness and zooming, as well as measuring specific lesions using 
calipers. It also offers views of both composite color and single-
wavelength images. We compared the images obtained at the 
different wavelengths to better differentiate the level at which 
the lesions were located; unlike the longer red laser wavelength, 
the green laser cannot penetrate significantly below the retinal 
pigment epithelium. Two experienced retina specialists inde-
pendently graded the images. They had not previously partici-
pated in patient examinations and were masked to all additional 
information such as visual acuity or clinical symptoms. They 
could, however, decline assigning a grade due to insufficient 
image quality, which was defined as not covering at least the 
central 60° and both the macula and the optic disc.
Measurements included are the following:
–  Location of the lesion: margin touching the optic disc 
according to the Shields et al12 definition (yes/no);
–  Existence of subretinal fluid at or surrounding the 
  pigmented lesion (yes/no);
–  Lesion appearance in red channel (dark/bright/mixed);
–  Lesion appearance in green channel (dark/bright/
mixed);
–  Lesion size (transversal and longitudinal diameter in   pixels). 
The maximum diameter was measured on Optomap. 
Measurements were standardized according to individual 
optic disc size defined as the mean horizontal and vertical 
disc diameters. For this known average, planimetry mean 
diameters of 1.92 mm vertically and 1.76 mm horizontally 
were used according to Jonas et al.22
Irregular lesion brightness or drusen was described and 
in case of major irregularity, the lesion appearance was 
graded as “mixed”. The first step in analysis of the obtained 
data was to prepare a scatter plot of measurements of the 
tumor basal diameters determined from Optomap images 
and those estimated from B-scan US images and perform 
correlation analysis on the plotted points of the tumor base 
on Optomap to US B-scan measurements. In a second step, 
we compared the Optomap imaging characteristics from the 
two-wavelength SLO images with the clinical definition and 
findings in the nevi and melanoma groups. To minimize bias 
from including pretreated melanoma patients in the study, we 
performed reanalysis excluding those 9 patients with signs of 
radiation. We collected and analyzed all data using SPSS 17.0 
for   Windows (SPSS Inc, Chicago, IL, USA), and a P value 
,0.05 was considered statistically significant.
Results
Correlation of Optomap imaging  
with Us measurements
Measurements of tumor base correlated statistically significant 
between SLO and US with r = 0.61 (T-direction, Spearman) and 
r = 0.51 (L-direction; Figure 1A and B). Optomap   measurements 
were statistically significantly higher (P , 0.001) than US for 
measurements in the T-direction, yielding a mean difference of 
2.8 mm. However, US and SLO measurements did not differ 
significantly in the L-direction (Wilcoxon).
imaging characteristics nevi vs melanoma 
with Optomap
The Optomap imaging details obtained in the two groups 
(nevi vs melanoma) are shown in Table 1 for the image 
characteristics investigated. With SLO imaging, malignant 
lesions typically appeared dark on the red laser channel and 
bright on the green laser channel. Figures 2–4 give repre-
sentative examples for Optomap imaging of malignant vs 
benign pigmented fundus lesion.
group differentiation by Optomap  
image features
Based only on the simple, mostly binary characteristics of a 
lesion’s appearance with Optomap imaging, a binary logistic Clinical Ophthalmology 2010:4
Figure 1 Base diameters of lesions measured in Us and Optomap. A) T-direction and B) L-direction.
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Table 1 imaging characteristics nevi vs melanoma
Characteristics  
on optomap
Nevi group,  
n = 20
Melanoma group,  
n = 29
Statistically  
significant difference  
nevi–melanoma,  
ANOVA, post hoc  
testing
Melanoma subgroup  
without any signs of 
radiation therapy,  
n = 20 out of 29
Clinical melanoma 
characteristics as 
defined by Shields 
and Shields11
Location touching  
optic disc
3 (15%) 8 (28%) ns 5 (25%) M = margin touch  
optic disc
Subretinal fluid 7 (35%) 14 (48%) ns 13 (65%) F = subretinal fluid
red channel imaging 12 dark  
7 bright  
1 mixeda
23 dark  
4 bright  
2 mixeda
ns 16 dark  
2 bright  
2 mixeda
O = orange pigment
green channel  
imaging
2 dark  
11 bright  
7 mixeda
6 dark  
22 bright  
1 mixeda
P = 0.011 3 dark  
16 bright  
1 mixeda
size T, in mm  
(mean ± sD)
8.18 ± 3.77 15.59 ± 4.69 P , 0.001 13.79 ± 4.26 T = thickness 
.2 mm; .1mm  
(for metastasis)
size L, in mm 
(mean ± sD)
7.88 ± 3.75 13.67 ± 4.00 P , 0.001 12.62 ± 4.49
Clinical parameter (not included in this imaging study) s = symptoms
Only available at follow-up examination g = growth  
(for metastasis)
Note: aMixed, irregular pattern not allowing a binary classification.
Abbreviations: ns, not significant; SD, standard deviation; ANOVA, analysis of variance.
regression analysis was calculated to obtain a simple overall 
predictor for malignancy. This relied only on the brightness 
imaging features available from the Optomap images and 
yielded a sensitivity of 76% at a specificity of 70%. The green 
channel (odd ratio [OR], 0.23; P = 0.02) was more predictive 
than the red channel (OR, 0.65; not significant). Overall fit 
was low with a Nagelkerke R2 of 0.20.
If in addition the T-diameter and L-diameter with Optomap 
imaging, contact with the optic disc and existence of subretinal 
fluid were considered, a 90% sensitivity at a 82% specificity 
was obtained. The overall Nagelkerke R2 reached 0.63 with the 
strongest predictors being subretinal fluid (OR, 2.1) and lesion 
size (T-direction OR, 1.5; L-direction OR, 1.1). The green 
and red channel images on Optomap retained a similarly high 
importance (green channel OR, 0.5; red channel OR, 0.45).
Discussion
Choroidal melanomas account for the largest proportion 
of malignant melanomas after those involving skin and 
are the most frequent primary intraocular tumor.1 Due to Clinical Ophthalmology 2010:4
Figure 2 A) Optomap composite image showing the typical appearance of an untreated choroidal melanoma (red and green channel superimposed). B) Detail of the fundus 
image from Figure 2A, as viewed with the specific Optomap viewing software (composite image on the left, red and green separation on the right). The lesion appears dark 
in the red channel and bright in green channel. C) red separation image (untreated melanoma). D) green separation image (untreated melanoma).
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their   malignancy and the very poor prognosis associated 
with progressing tumors, early detection is extremely 
important.8–12 Diagnostic criteria for differentiating malignant 
from nonmalignant lesions are   controversial and often seem 
arbitrary.4,23,24 However, size (mainly a lesion’s thickness but 
also the basal diameter) is one of the most important clinical 
features. If a lesion enlarges convincingly during follow-up, 
most   ophthalmologists classify the tumor as at least probable 
choroidal melanoma.25   Nevertheless, clinical classification 
of pigmented choroidal lesions is often a great challenge for 
ophthalmologists.13 One reason for that may be a substantial 
overlap between choroidal nevi and melanoma, particularly 
for tumors between 1.5 and 3 mm of thickness having a 
basal diameter between 5 and 9 mm.25 Standardized A-scan 
US has become a valuable aid to establish the diagnosis of 
choroidal melanoma in such cases.20 However, this technique 
is not generally available; further, it is time consuming and 
requires an experienced operator. Therefore, especially for 
screening purposes, alternative, easy-to-handle diagnostic 
tools would be preferred.
The SLO Optomap P200MA is a nonmydriatic ultra-
wide-field fundus imaging system that uses two laser 
  wavelengths and is able to image up to 200° of the retina 
with 1 scan. It, therefore, allows suspicious lesions to be 
easily detected and has substantial screening abilities for 
several retinal diseases. In addition, separating the two 
laser scans provides further information because red laser 
better penetrates the deeper layers of the retina and the 
choroid, and green, red-free laser provides better images 
of the superficial layers of the retina and retinal vessels.26 
Therefore, we investigated the diagnostic properties of 
nonmydriatic SLO imaging with two laser wavelengths 
A
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BClinical Ophthalmology 2010:4
with the Optomap Panoramic 200MA imaging device as a 
potential screening tool to differentiate clinically diagnosed 
melanocytic choroidal tumors.
This first, limited series yielded data that allowed differ-
entiating malignant ocular tumors from nonmalignant lesions 
with high diagnostic accuracy. It must be kept in mind, though, 
that for the diagnostic features developed in our   current 
patient group sensitivity and specificity are “theoretical”: 
those need to be proven and recalculated in an independent 
patient group. By separating red and green laser scans alone, 
we could evaluate very simple image properties, which pro-
vided a diagnostic sensitivity of 76% and a specificity of 70% 
without assessment of any other clinical parameters. Aiming 
to enhance diagnostic accuracy, Shields and Shields11 analyzed 
1,287 patients presenting different choroidal lesions including 
both choroidal nevi and choroidal melanoma. As a result of 
their investigation, they identified five predictive clinical 
  features of small choroidal melanoma growth to help clinicians 
better differentiate   suspect lesions: tumor thickness .2 mm, 
presence of   subretinal fluid,   clinical symptoms, orange pigment 
overlying the surface of the tumor, and tumor margins touching 
or within 3 mm of the optic disc.12 These combined clinical 
parameters in   combination allowed   distinguishing malignant 
from clinically as nonmalignant diagnosed   melanocytic 
  choroidal tumors with high accuracy.11
Therefore, another aim of our study was to prove 
whether combining some of these criteria from Shields 
and Shields11 with the specific imaging characteristics 
from Optomap   Panoramic 200MA images could improve 
diagnostic   precision. We found that measurement of the 
submit your manuscript | www.dovepress.com
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Figure 3 A) Optomap composite image showing the typical appearance of a choroidal nevus (red and green channel superimposed). Due to the nonconfocal sLO imaging, some 
bright spots anterior to the lesion are imaged and some lashes in the upper part of the image also appear in focus. B) Detail of the according fundus image from Figure 3A, as 
viewed with the specific Optomap viewing software (composite image on the left, red and green separation on the right). The lesion appears dark in the red channel and dark 
in green channel. Due to the nonconfocal sLO imaging, some bright spots anterior to the lesion. C) red separation image (nevus). D) green separation image (nevus).
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tumor base, combined with an evaluation of subretinal 
fluid, assessment of the lesion locations on the ocular 
fundus, and the specific   imaging criteria from Optomap 
led to a significant   improvement of diagnostic accuracy 
allowing   differentiation of malignant from   nonmalignant 
ocular tumors in 90% of cases. This appears to exceed 
the diagnostic accuracy of photographic fundus imaging, 
although validation in an independent series is required. 
Indeed, standardized A-scan US conducted by an experi-
enced operator might allow higher accuracy; however, with 
less experience of the investigator, diagnostic accuracy 
drops dramatically. Further, the   technique itself might be 
less tolerated by patients than a simple   imaging procedure 
and it is not widely available. In contrast, the Optomap 
imaging system is noninvasive and easy to handle. It also 
permits   telescreening because data files from Optomap can 
be easily transferred online and can be examined anywhere 
in the world.
In summary, we showed that nonmydriatic SLO imaging 
with two laser wavelengths allowed differentiating malignant 
ocular tumors from nonmalignant lesions with relatively high 
accuracy. Lesion size measurements correlated reasonably well 
with US measurements. Additional parameters to describe and 
differentiate lesions may further increase diagnostic properties, 
and larger patient series are required to validate our findings.
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Figure 4 A) Optomap composite image showing the typical appearance of a choroidal melanoma after radiation therapy (red and green channel superimposed). B) Detail of 
the according fundus image from Figure 4A, as viewed with the specific Optomap viewing software (composite image on the left, red and green separation on the right). The 
lesion appears bright in the red channel and bright in green channel. C) red separation image (treated melanoma). D) green separation image (treated melanoma).
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